-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Changxing Island Economic Zone Management Committee and Jiangsu Changzhou Sunshine Pharmaceutical Co.
, Ltd.
signed a letter of intent for project investment and cooperation, and the project of a high-end polyimide monomer and pharmaceutical intermediate product production, research and development integration base project with a total investment of 500 million yuan was officially settled.
Changxing Island
.
According to reports, after preliminary negotiation, Changzhou Sunshine Pharmaceutical Co.
, Ltd.
and Shanghai Huayi Group Investment Co.
, Ltd.
jointly invested and established a project company in Changxing Island Economic Zone to build the integration of production, research and development of high-end polyimide monomers and pharmaceutical intermediates.
base project
.
The total investment of the project is about 500 million yuan.
It is planned to be located in Changxing Island Fine Chemical Innovation Park, and the construction will be completed in two phases
.
Yang Guangzhi said that the new fine chemical material project jointly invested and constructed by Sunshine Pharmaceutical and Shanghai Huayi has high technological content and broad market prospects, which will inject new impetus into the development and expansion of the real economy and the construction of a modern industrial system in Changxing Island
.
Hu Guoyi said that the choice of Changxing Island is based on the business environment, location advantages and good development prospects of the petrochemical industry
.